ClearPoint Neuro is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Joseph Michael Burnett, with a market cap of $354.5M.
Based on Q1 2026 filing
Common questions about ClearPoint Neuro
ClearPoint Neuro (CLPT) has a market capitalization of $354.5M and trades on NASDAQ.
ClearPoint Neuro has approximately 107 employees.